Lo AW - Search Results

1

New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics: A Review.

Das S, Rousseau R, Adamson PC, Lo AW. Das S, et al. Among authors: lo aw. JAMA Oncol. 2018 Sep 1;4(9):1274-1280. doi: 10.1001/jamaoncol.2018.1739. JAMA Oncol. 2018. PMID: 29860493 Review.

2

Parallel discovery of Alzheimer's therapeutics.

Lo AW, Ho C, Cummings J, Kosik KS. Lo AW, et al. Sci Transl Med. 2014 Jun 18;6(241):241cm5. doi: 10.1126/scitranslmed.3008228. Sci Transl Med. 2014. PMID: 24944190

3

Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture.

Fojo T, Mailankody S, Lo A. Fojo T, et al. JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1225-36. doi: 10.1001/jamaoto.2014.1570. JAMA Otolaryngol Head Neck Surg. 2014. PMID: 25068501

4

Health, Wealth, and the 21st Century Cures Act.

Lo AW, Philipson TJ, von Eschenbach AC. Lo AW, et al. JAMA Oncol. 2016 Jan;2(1):17-8. doi: 10.1001/jamaoncol.2015.4221. JAMA Oncol. 2016. PMID: 26513279 No abstract available.

5

Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology.

Montazerhodjat V, Chaudhuri SE, Sargent DJ, Lo AW. Montazerhodjat V, et al. Among authors: lo aw. JAMA Oncol. 2017 Sep 14;3(9):e170123. doi: 10.1001/jamaoncol.2017.0123. Epub 2017 Sep 14. JAMA Oncol. 2017. PMID: 28418507 Free PMC article.

6

Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program.

Das S, Lo AW. Das S, et al. Among authors: lo aw. Contemp Clin Trials. 2017 Nov;62:168-174. doi: 10.1016/j.cct.2017.09.002. Epub 2017 Sep 9. Contemp Clin Trials. 2017. PMID: 28899813 Clinical Trial.

7

Acceleration of rare disease therapeutic development: a case study of AGIL-AADC.

Das S, Huang S, Lo AW. Das S, et al. Among authors: lo aw. Drug Discov Today. 2019 Mar;24(3):678-684. doi: 10.1016/j.drudis.2018.12.006. Epub 2019 Jan 2. Drug Discov Today. 2019. PMID: 30610920 Review.

8

Commercializing biomedical research through securitization techniques.

Fernandez JM, Stein RM, Lo AW. Fernandez JM, et al. Among authors: lo aw. Nat Biotechnol. 2012 Oct;30(10):964-75. doi: 10.1038/nbt.2374. Nat Biotechnol. 2012. PMID: 23023199

9

Financing drug discovery for orphan diseases.

Fagnan DE, Gromatzky AA, Stein RM, Fernandez JM, Lo AW. Fagnan DE, et al. Among authors: lo aw. Drug Discov Today. 2014 May;19(5):533-8. doi: 10.1016/j.drudis.2013.11.009. Epub 2013 Nov 20. Drug Discov Today. 2014. PMID: 24269746 Free article. Review.

10

Financing translation: analysis of the NCATS rare-diseases portfolio.

Fagnan DE, Yang NN, McKew JC, Lo AW. Fagnan DE, et al. Among authors: lo aw. Sci Transl Med. 2015 Feb 25;7(276):276ps3. doi: 10.1126/scitranslmed.aaa2360. Sci Transl Med. 2015. PMID: 25717096 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page